Breaking News
February 20, 2018 - Blood or marrow transplantation survivors have higher risk of cognitive impairment
February 20, 2018 - Booze Beats Pot at Being Unhealthy: Oregon Poll
February 20, 2018 - Morning Break: ’20 Years Late’; Drugs in the Dirt; Catching Flu in the Dorm
February 20, 2018 - Another piece to the puzzle in naked mole rats’ long, cancer-free life
February 20, 2018 - Scientists identify four viruses that can produce insulin-like hormones
February 20, 2018 - New e-Health solution developed to prevent cardiovascular disease, dementia in senior citizens
February 20, 2018 - New genetic risk score could help guide screening decisions for prostate cancer
February 20, 2018 - Study finds higher risk of stroke among blacks with atrial fibrillation than whites
February 20, 2018 - Physical activity could be used as strategy for diabetes prevention
February 20, 2018 - Researchers develop sensing method for early detection of cancer and diabetes
February 20, 2018 - New wearable electronics could be game-changer for stroke rehabilitation
February 20, 2018 - Immune history influences person’s response to flu vaccine
February 20, 2018 - Serenity Now! Learn to Have Patience with Patients
February 20, 2018 - Computer simulation addresses the problem of blood clotting
February 20, 2018 - Persistent bloating can be a sign of ovarian cancer, warns charity
February 20, 2018 - Key protein involved in epigenetic regulation of gene expression guides skin cell renewal
February 20, 2018 - Heart attack symptoms often missed in women
February 20, 2018 - Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms
February 20, 2018 - Study reveals functional dynamics of ion channels
February 20, 2018 - Study explores link between mortality risk and combustible tobacco use
February 20, 2018 - ‘She Trusted Me, and I’d Turned Her Away’
February 20, 2018 - AbbVie and Voyager Therapeutics collaborate to develop new treatments for tauopathies
February 20, 2018 - Fast food makes the immune system more aggressive in the long term
February 20, 2018 - Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s
February 20, 2018 - Overcoming Negative Reviews | Medpage Today
February 20, 2018 - MyD88—villain of allergies and asthma
February 20, 2018 - Food scientists develop rapid screening technique to detect pesticide residue in vegetables
February 20, 2018 - Lab-grown cerebellar cells may help explain how ASD develops at molecular level
February 20, 2018 - Scientists explore connection between bad sleep habits and stiff blood vessels
February 20, 2018 - New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy
February 20, 2018 - Do You Really Need My Signature on That?
February 20, 2018 - HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection
February 20, 2018 - Diabetes does not increase work-loss years due to early retirement
February 20, 2018 - Researchers aim to find out how PTSD affects decisions of police
February 20, 2018 - UH Cleveland Medical Center explores novel treatments for uterine fibroids
February 20, 2018 - Flu Vax Efficacy 25% Against Predominant H3N2 Strain So Far
February 20, 2018 - HIV screening most optimal at 25 years of age if no risk factors
February 20, 2018 - Loyola Medicine primary care physician offers advice to minimize risk of flu
February 20, 2018 - Safe sleep recommendations for parents that may help reduce child’s risk of SUID
February 20, 2018 - Why Do So Few Docs Have Buprenorphine Waivers?
February 20, 2018 - Low levels of alcohol good for the brain
February 20, 2018 - Experimental treatment improves invisible symptoms of a man with spinal cord injury
February 20, 2018 - Myriad’s EndoPredict offers better prediction of breast cancer recurrence, analysis shows
February 20, 2018 - Researchers identify fifteen genes that determine our facial features
February 20, 2018 - Morning Break: New Health IT Player; Luxturna No Bargain; Nuclear Freakout
February 20, 2018 - How does it compare? Hospice care at home, at assisted living facility, at nursing home
February 19, 2018 - Scientists develop water-soluble warped nanographene for bioimaging
February 19, 2018 - It’s Not Your Imagination: You’re Hungrier After Losing Weight
February 19, 2018 - Antihypertensive Use At Delivery Rising in Preeclampsia
February 19, 2018 - A centuries-old math equation used to solve a modern-day genetics challenge
February 19, 2018 - Liquid biopsies could be used as new predictive marker for metastatic TNBC
February 19, 2018 - Russian researchers develop new multi-layered biodegradable scaffolds
February 19, 2018 - Are ‘Vaccine Skeptics’ Responsible for Flu Deaths?
February 19, 2018 - Hidden genetic effects behind immune diseases may be missed, study suggests
February 19, 2018 - Emergency nurses experience regular verbal and physical abuse
February 19, 2018 - Study sheds light on biology that guides behavior across different stages of life
February 19, 2018 - Morning Break: Transgender Breast Feeding; Brazilian ‘Pro-Vaxxers’; Post-Stroke Exercise
February 19, 2018 - Meningitis vaccination strategy in Africa found to be effective, economical
February 19, 2018 - Researchers uncover how excess calcium may influence development of Parkinson’s disease
February 19, 2018 - Psoriasis drug also effective at reducing aortic inflammation
February 19, 2018 - Excess emissions can make serious contributions to air pollution, study shows
February 19, 2018 - Researchers reveal potential biological roots behind individuality
February 19, 2018 - Diabetes Drugs Differ on HF; School-Based Obesity Program Flop; Plaque Type in ACS
February 19, 2018 - Surgical infections linked to drug-resistant bugs, study suggests
February 19, 2018 - Poor awareness may hinder a child’s early dental care
February 19, 2018 - Research finds rising trend in incidence of merkel cell carcinoma
February 19, 2018 - Researchers uncover Ras protein’s role in uncontrolled cancer growth
February 19, 2018 - FDA Approves Apalutamide (Erleada) to Help Curb a Tough-to-Treat Prostate Cancer
February 19, 2018 - Educational Tool Boosts Cervical Length Screening
February 19, 2018 - Spider’s web inspires removable implant that may control type 1 diabetes
February 19, 2018 - Scientists develop fluorescent probe to identify cancer stem cells
February 19, 2018 - University Hospital of Santiago de Compostela participates in large pancreatic cancer study
February 19, 2018 - New blood test shows promise to revolutionize diagnosis of tick-borne diseases
February 19, 2018 - Report: Use, Not Price, Drives State Health Costs
February 19, 2018 - Emergency services crews often unprepared for diabetic crises
February 19, 2018 - Scientists in Sweden create DNA nanowires that offer hope for treatment of diseases
February 19, 2018 - ID Break: Clean Hands, Fewer Abx; $11 Million HIV Cure?; MenB Vax for Kids
February 19, 2018 - Patient exposure to X-rays depends on how dentists are paid
February 19, 2018 - Study reveals parents’ views toward children’s tanning bed use
February 19, 2018 - Shot may help reduce risk of shingles
Year in Review: Ophthalmology | Medpage Today

Year in Review: Ophthalmology | Medpage Today

image_pdfDownload PDFimage_print

The field of ophthalmology started to gain useful insights into the state of clinical practice, as data emerged from the world’s largest, dedicated ophthalmology clinical registry.

Several studies based on data from the American Academy of Ophthalmology’s Intelligent Research in Sight (IRIS) registry were reported during 2017. Others are expected to follow in the near future, providing information that has the potential to shape clinical practice today and for years to come.

One of several IRIS-based studies reported at the 2017 AAO annual meeting suggested that diabetic macular edema (DME) is vastly undertreated. Even when patients are treated, many receive a suboptimal number of injections of anti-VEGF therapy.

Another study based on data from IRIS showed that use of anti-VEGF agents in clinical practice leads to better control of intraocular pressure (IOP) than was suggested by clinical trials. Mathew MacCumber, MD, of Rush University Medical Center in Chicago, reported rates of clinically significant IOP elevation of 2% to 3%. In contrast, clinical trials of aflibercept (Eylea) and ranibizumab (Lucentis) showed rates of sustained, clinically significant IOP elevation as high as 24%.

Comparisons with untreated eyes also showed variation among the available anti-VEGF agents with respect to the rates of sustained, clinically significant elevations in IOP. Specifically, ranibizumab and bevacizumab (Avastin) were associated with higher rates of clinically significant IOP elevation than with aflibercept.

A study involving patients with moderate to severe nonproliferative diabetic retinopathy showed that three-fourths of them had at least a two-step improvement in disease status when treated with ranibizumab. Patients with more severe disease tended to derive more benefit from the anti-VEGF therapy.

Following the success of bevacizumab, another cancer drug showed potential as an effective and potentially less expensive treatment for diabetic macular edema. A randomized trial showed that patients treated with small doses of ziv-aflibercept (Zaltrap) had greater improvement in visual acuity than did patients treated with bevacizumab.

Data from another randomized trial involving patients with DME showed that adding dexamethasone to ranibizumab did not improve visual acuity over the use of ranibizumab alone. Many patients with DME have persistent retinal thickening and associated vision deterioration despite having anti-VEGF therapy. Dexamethasone has both anti-VEGF and anti-inflammatory properties, leading to the hypothesis that using it as an add-on to primary anti-VEGF therapy would lead to better results, said Raj Maturi, MD, of the Midwest Eye Institute in Indianapolis.

Possibly an underappreciated risk associated with diabetic retinopathy is an increased risk of falling.

Several notable studies focused on eye infections and antibiotic therapy. An analysis of bacterial isolates from patients with endophthalmitis revealed a high proportion of antibiotic-resistant organisms; half of coagulase-negative staphylococci and 40% of Staphylococcus aureus demonstrated methicillin resistance.

Patients with adenoviral conjunctivitis had high rates of clinical resolution and viral eradication when treated with SHP640 (dexamethasone/povidone-iodine ophthalmic suspension). The therapy had a rapid onset of activity, as a third of patients had clinical resolution within 6 days of starting treatment and 80% had virus eradication. A substantial proportion of patients had virus eradication within 3 days, with or without dexamethasone.

Prophylactic intracameral antibiotic therapy has proven to be safe and efficacious for patients undergoing cataract surgery and may have advantages over other options for prophylaxis. On the other hand, transzonular antibiotic delivery also has its share of supporters.

The U.S. Preventive Services Task Force recommended vision testing for preschoolers ages 3 to 5 but found the evidence insufficient to make a recommendation for screening younger children.

Another study added fuel to the controversy over whether vitamins or nutrients can help prevent age-related macular degeneration (AMD). A systematic review found evidence lacking to support the use of vitamin E, beta-carotene, vitamin C, or a widely used multivitamin to prevent AMD.

A glaucoma expert warned of the risks posed by corticosteroid therapy, regardless of the route of administration.

Laser treatment showed potential as an option for managing eye “floaters.” One small randomized trial showed that more than half of patients who underwent laser treatment had symptomatic improvement compared with 9% of patients who underwent a sham procedure.

A trial of gene transfer for an inherited retinal disorder led to vision improvement in 93% of patients. The investigators reported that 27 of 29 patients with Leber congenital amaurosis could see well enough to navigate a maze in moderate to low light after treatment with voretigene neparvovec (Luxturna).


Tagged with:

About author

Related Articles